| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 48 |
| 1 | ETANERCEPT | 47 |
| 2 | METHOTREXATE | 44 |
| 3 | ADALIMUMAB | 43 |
| 4 | METFORMIN | 43 |
| 5 | LEFLUNOMIDE | 42 |
| 6 | TOFACITINIB | 42 |
| 7 | AZATHIOPRINE | 40 |
| 8 | METFORMIN ER 500 MG | 38 |
| 9 | METFORMIN ER 750 MG | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NICOTINAMIDE | 19 | 0.0074 |
| 1 | ESOMEPRAZOLE SODIUM | 15 | 0.0062 |
| 2 | TOLNAFTATE | 7 | 0.0053 |
| 3 | GOLD | 21 | 0.0036 |
| 4 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 2 | 0.0026 |
| 5 | ERGOCALCIFEROL | 33 | 0.0011 |
| 6 | NORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0011 |
| 7 | NADOLOL | 8 | 0.0011 |
| 8 | SARILUMAB | 26 | 0.0009 |
| 9 | HYALURONIC ACID | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 51 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 44 |
| 2 | Antirheumatic Agent [EPC] | 42 |
| 3 | Purine Antimetabolite [EPC] | 40 |
| 4 | Aminosalicylate [EPC] | 36 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 34 |
| 6 | Provitamin D2 Compound [EPC] | 33 |
| 7 | Proton Pump Inhibitor [EPC] | 28 |
| 8 | Vitamin C [EPC] | 25 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 33 | 0.0011 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Purine Antimetabolite [EPC] | 40 | 0.0004 |
| 3 | Antirheumatic Agent [EPC] | 42 | 0.0004 |
| 4 | Aminosalicylate [EPC] | 36 | 0.0004 |
| 5 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0003 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 34 | 0.0002 |
| 8 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 9 | Bile Acid [EPC] | 4 | 0.0002 |